vs

Side-by-side financial comparison of Emerson Electric (EMR) and Sherwin-Williams (SHW). Click either name above to swap in a different company.

Sherwin-Williams is the larger business by last-quarter revenue ($5.7B vs $4.3B, roughly 1.3× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 9.4%, a 4.5% gap on every dollar of revenue. On growth, Sherwin-Williams posted the faster year-over-year revenue change (6.8% vs 4.1%). Over the past eight quarters, Emerson Electric's revenue compounded faster (-0.3% CAGR vs -4.9%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Sherwin-Williams is an American paints and coatings company based in Cleveland, Ohio. It is primarily engaged in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products with operations in over 120 countries. As of 2024, it is the largest coatings company in the world by revenue.

EMR vs SHW — Head-to-Head

Bigger by revenue
SHW
SHW
1.3× larger
SHW
$5.7B
$4.3B
EMR
Growing faster (revenue YoY)
SHW
SHW
+2.7% gap
SHW
6.8%
4.1%
EMR
Higher net margin
EMR
EMR
4.5% more per $
EMR
13.9%
9.4%
SHW
Faster 2-yr revenue CAGR
EMR
EMR
Annualised
EMR
-0.3%
-4.9%
SHW

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EMR
EMR
SHW
SHW
Revenue
$4.3B
$5.7B
Net Profit
$605.0M
$534.7M
Gross Margin
53.2%
49.1%
Operating Margin
17.8%
Net Margin
13.9%
9.4%
Revenue YoY
4.1%
6.8%
Net Profit YoY
3.4%
6.1%
EPS (diluted)
$1.07
$2.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
SHW
SHW
Q1 26
$5.7B
Q4 25
$4.3B
$5.6B
Q3 25
$4.9B
$6.4B
Q2 25
$4.6B
$6.3B
Q1 25
$4.4B
$5.3B
Q4 24
$4.2B
$5.3B
Q3 24
$4.6B
$6.2B
Q2 24
$4.4B
$6.3B
Net Profit
EMR
EMR
SHW
SHW
Q1 26
$534.7M
Q4 25
$605.0M
$476.8M
Q3 25
$637.0M
$833.1M
Q2 25
$586.0M
$754.7M
Q1 25
$485.0M
$503.9M
Q4 24
$585.0M
$480.1M
Q3 24
$996.0M
$806.2M
Q2 24
$329.0M
$889.9M
Gross Margin
EMR
EMR
SHW
SHW
Q1 26
49.1%
Q4 25
53.2%
48.5%
Q3 25
51.9%
49.2%
Q2 25
52.6%
49.4%
Q1 25
53.5%
48.2%
Q4 24
53.5%
48.6%
Q3 24
51.3%
49.1%
Q2 24
52.8%
48.8%
Operating Margin
EMR
EMR
SHW
SHW
Q1 26
Q4 25
17.8%
11.4%
Q3 25
16.4%
16.7%
Q2 25
16.1%
15.6%
Q1 25
14.2%
12.3%
Q4 24
18.6%
11.6%
Q3 24
14.7%
21.4%
Q2 24
10.4%
22.5%
Net Margin
EMR
EMR
SHW
SHW
Q1 26
9.4%
Q4 25
13.9%
8.5%
Q3 25
13.1%
13.1%
Q2 25
12.9%
12.0%
Q1 25
10.9%
9.5%
Q4 24
14.0%
9.1%
Q3 24
21.6%
13.1%
Q2 24
7.5%
14.2%
EPS (diluted)
EMR
EMR
SHW
SHW
Q1 26
$2.15
Q4 25
$1.07
$1.91
Q3 25
$1.12
$3.35
Q2 25
$1.04
$3.00
Q1 25
$0.86
$2.00
Q4 24
$1.02
$1.90
Q3 24
$1.74
$3.18
Q2 24
$0.57
$3.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
SHW
SHW
Cash + ST InvestmentsLiquidity on hand
$216.9K
Total DebtLower is stronger
$7.6B
$11.7M
Stockholders' EquityBook value
$20.3B
$4.4M
Total Assets
$41.9B
$26.4M
Debt / EquityLower = less leverage
0.37×
2.64×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
SHW
SHW
Q1 26
$216.9K
Q4 25
$207.2M
Q3 25
$241.5M
Q2 25
$269.8M
Q1 25
$199.8M
Q4 24
$210.4M
Q3 24
$238.2M
Q2 24
$200.0M
Total Debt
EMR
EMR
SHW
SHW
Q1 26
$11.7M
Q4 25
$7.6B
$9.7B
Q3 25
$8.9B
$9.7B
Q2 25
$8.3B
$9.0B
Q1 25
$8.2B
$9.0B
Q4 24
$6.6B
$9.2B
Q3 24
$7.7B
$9.2B
Q2 24
$7.1B
$9.0B
Stockholders' Equity
EMR
EMR
SHW
SHW
Q1 26
$4.4M
Q4 25
$20.3B
$4.6B
Q3 25
$20.3B
$4.4B
Q2 25
$19.9B
$4.4B
Q1 25
$19.2B
$4.1B
Q4 24
$20.5B
$4.1B
Q3 24
$21.6B
$4.2B
Q2 24
$20.8B
$3.8B
Total Assets
EMR
EMR
SHW
SHW
Q1 26
$26.4M
Q4 25
$41.9B
$25.9B
Q3 25
$42.0B
$26.2B
Q2 25
$42.5B
$25.4B
Q1 25
$42.0B
$24.6B
Q4 24
$42.6B
$23.6B
Q3 24
$44.2B
$24.0B
Q2 24
$45.6B
$23.7B
Debt / Equity
EMR
EMR
SHW
SHW
Q1 26
2.64×
Q4 25
0.37×
2.10×
Q3 25
0.44×
2.18×
Q2 25
0.42×
2.04×
Q1 25
0.42×
2.17×
Q4 24
0.32×
2.28×
Q3 24
0.36×
2.22×
Q2 24
0.34×
2.39×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
SHW
SHW
Operating Cash FlowLast quarter
$699.0M
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
2.4%
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
SHW
SHW
Q1 26
Q4 25
$699.0M
$1.1B
Q3 25
$3.1B
$1.3B
Q2 25
$1.1B
$1.1B
Q1 25
$241.0M
$-61.1M
Q4 24
$777.0M
$934.5M
Q3 24
$3.3B
$1.1B
Q2 24
$1.1B
$1.2B
Free Cash Flow
EMR
EMR
SHW
SHW
Q1 26
Q4 25
$602.0M
$862.1M
Q3 25
$2.7B
$1.1B
Q2 25
$977.0M
$931.1M
Q1 25
$154.0M
$-250.4M
Q4 24
$694.0M
$634.5M
Q3 24
$2.9B
$839.4M
Q2 24
$998.0M
$952.0M
FCF Margin
EMR
EMR
SHW
SHW
Q1 26
Q4 25
13.9%
15.4%
Q3 25
54.9%
17.5%
Q2 25
21.5%
14.7%
Q1 25
3.5%
-4.7%
Q4 24
16.6%
12.0%
Q3 24
63.1%
13.6%
Q2 24
22.8%
15.2%
Capex Intensity
EMR
EMR
SHW
SHW
Q1 26
2.4%
Q4 25
2.2%
4.1%
Q3 25
8.9%
3.1%
Q2 25
2.0%
2.9%
Q1 25
2.0%
3.6%
Q4 24
2.0%
5.7%
Q3 24
9.1%
3.8%
Q2 24
2.1%
4.0%
Cash Conversion
EMR
EMR
SHW
SHW
Q1 26
Q4 25
1.16×
2.29×
Q3 25
4.86×
1.57×
Q2 25
1.83×
1.47×
Q1 25
0.50×
-0.12×
Q4 24
1.33×
1.95×
Q3 24
3.35×
1.33×
Q2 24
3.31×
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

SHW
SHW

Segment breakdown not available.

Related Comparisons